The Role of Red Cell Characteristics, Angiogenesis, Viscosity and Oxygenation in the Pathophysiology of Sickle Cell Related Retinopathy
NCT06396403 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 68
Last updated 2024-11-15
Summary
Objective:
to gain insight in the pathogenesis, to identify biomarkers to recognize patients at risk for proliferative SCR and to investigate its associations with clinical and laboratory characteristics.
Endpoints:
The investigators will determine the difference in the above named parameters between patients with and without PSCR
Study design:
This case control study will include adult sickle cell disease patients with the HbSS or HbSC genotype. For both genotypes, 20 patients without sickle cell retinopathy (SCR) and 20 patients with PSCR will be included, resulting in a total of 80 patients. Venous blood samples and retinal imaging scans will be collected for each included patient.
Conditions
- Sickle Cell Retinopathy
- Sickle Cell Disease
- Sickle Cell SC Disease
- Sickle Cell-SS Disease
Interventions
- OTHER
-
Collection of venous blood samples
collection includes 1 EDTA tube and 1 Sarstedt S-Monovette tube of 5 mL
Sponsors & Collaborators
-
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
lead OTHER
Principal Investigators
-
Bart J Biemond, MD PhD · Department of Hematology, Amsterdam UMC, Amsterdam, The Netherlands
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-06-13
- Primary Completion
- 2024-06-17
- Completion
- 2024-06-17
Countries
- Netherlands
Study Locations
More Related Trials
-
Brain Structure and Neurocognitive Development in Sickle Cell Disease; a Longitudinal Cohort Study (BRICK Study)
NCT05564845 ·Status: UNKNOWN
-
Biological, Genetic and Environmental Involved in the Complications of Sickle Cell Disease
NCT04205123 ·Status: UNKNOWN
-
Anticoagulation For Pulmonary Hypertension in Sickle Cell Disease
NCT01036802 ·Status: TERMINATED ·Phase: PHASE2
-
SCRIPT: Sickle Cell Risk in Pregnancy Tool
NCT06529042 ·Status: ENROLLING_BY_INVITATION
-
Evaluation of the Hemostatic Potential in Sickle Cell Disease Patients
NCT02565082 ·Status: COMPLETED ·Phase: NA
-
Relationship Between Biological Phenotype, Clinical Severity of Sickle Cell Disease, and Blood Coagulation
NCT06619093 ·Status: NOT_YET_RECRUITING
-
The Effect of Rivaroxaban in Sickle Cell Disease
NCT02072668 ·Status: COMPLETED ·Phase: PHASE2
-
Hemostasis in Sickle Cell Disease--Infancy to Adulthood
NCT00005703 ·Status: COMPLETED
-
Transfusion in Sickle Cell Disease: Screening of Sickle Cell Disease Trait in Blood Donors
NCT03405688 ·Status: COMPLETED ·Phase: NA
-
A Low-Interventional Study of an Electronic Sickle Cell Disease Patient Reported Outcomes in Sickle Cell Participants
NCT06503458 ·Status: TERMINATED
-
Genotype -Phenotype Correlation of PKLR Variants With Pyruvate Kinase, 2,3-Diphosphglycerate and Adenosine Triphosphate Activities in Red Blood Cells of People With Sickle Cell Disease
NCT03685721 ·Status: RECRUITING
-
Screening Patients With Sickle Cell Disease for Kidney Damage
NCT02239016 ·Status: COMPLETED
-
Investigating the Mechanistic Effects of Mitapivat in Subjects With Sickle Cell Disease
NCT05675436 ·Status: ACTIVE_NOT_RECRUITING
-
A 3-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients
NCT01220115 ·Status: COMPLETED
-
Clinical and Laboratory Characteristics of Polycythemia Vera
NCT06134102 ·Status: COMPLETED
-
New, Previously Unknown, Uses of Optical Coherence Tomography Angiography (OCTA)
NCT03068702 ·Status: COMPLETED
-
Blood Flow and Pain Crises in People With Sickle Cell Disease
NCT01568710 ·Status: COMPLETED
-
Role of Inflammasome in Platelet Activation in Sickle Cell Disease Patient
NCT06986837 ·Status: COMPLETED
-
Early Diagnosis of Sickle Acute Chest Syndrome Using a Combination of Plasma Bimarkers and Chest Imaging
NCT03478917 ·Status: COMPLETED
-
Iron Mediated Vascular Disease in Sickle Cell Anemia Patients
NCT01239901 ·Status: COMPLETED
-
Biotin-Acridine Red Cell Exchange Kinetics
NCT07155031 ·Status: WITHDRAWN ·Phase: PHASE2
-
Sickle Cell Clinical Research and Intervention Program
NCT02098863 ·Status: RECRUITING
-
Study of Erythrocyte Parameters and Hypercoagulability in Sickle Cell Disease (SCD-TGA)
NCT05376046 ·Status: RECRUITING
-
A Study of Mitapivat in Participants With Sickle Cell Disease and Nephropathy
NCT06286046 ·Status: WITHDRAWN ·Phase: PHASE2
-
Microvessels and Heart Problems in Sickle Cell Disease
NCT01602809 ·Status: COMPLETED